 | Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021 finance.yahoo.com - April 10 at 8:55 AM |
 | Kymera Therapeutics (NASDAQ:KYMR) Stock Price Down 5.5% americanbankingnews.com - April 9 at 2:38 PM |
 | Kymera Therapeutics to Present New Results from Non-Interventional Study in Patients with Hidradenitis Suppurativa at the Society for Investigative Dermatology (SID) 2021 Annual Meeting finance.yahoo.com - April 9 at 12:18 PM |
 | Kymera Therapeutics (NASDAQ:KYMR) Sees Strong Trading Volume americanbankingnews.com - March 31 at 12:56 PM |
 | Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Consensus Recommendation of "Buy" by Analysts americanbankingnews.com - March 25 at 5:32 PM |
 | Kymera Therapeutics (NASDAQ:KYMR) Stock Price Down 6.4% americanbankingnews.com - March 25 at 11:37 AM |
 | Kymera Therapeutics Becomes Oversold (KYMR) nasdaq.com - March 24 at 1:01 PM |
 | Kymera Therapeutics (NASDAQ:KYMR) Price Target Cut to $69.00 americanbankingnews.com - March 23 at 11:08 AM |
 | Kymera Therapeutics (NASDAQ:KYMR) Trading 6.2% Higher americanbankingnews.com - March 22 at 2:42 PM |
 | Kymera Therapeutics (NASDAQ:KYMR) Shares Down 13.9% americanbankingnews.com - March 18 at 9:14 PM |
|
 | Bruce Booth Sells 229,350 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) Stock americanbankingnews.com - March 16 at 10:48 PM |
 | Kymera Therapeutics Appoints Elena Ridloff, CFA, to Board of Directors finance.yahoo.com - March 16 at 6:52 PM |
 | Kymera Therapeutics Inc (KYMR) CFO Bruce N. Jacobs Sold $601,500 of Shares finance.yahoo.com - March 16 at 12:51 AM |
 | Kymera Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides a Business Update finance.yahoo.com - March 11 at 7:42 AM |
 | Kymera Therapeutics Inc (KYMR) CFO Bruce N. Jacobs Sold $506,500 of Shares finance.yahoo.com - March 9 at 1:36 AM |
 | Kymera Therapeutics Inc (KYMR) CFO Bruce N. Jacobs Sold $895,600 of Shares finance.yahoo.com - March 5 at 8:48 PM |
 | Kymera Therapeutics Announces First-in-Human Dose in Phase 1 Trial of KT-474, a First-in-Class IRAK4 Protein Degrader to Treat Immune-Inflammatory Diseases finance.yahoo.com - March 2 at 8:10 AM |
 | Kymera Therapeutics to Present at Upcoming March Investor Conferences finance.yahoo.com - February 25 at 8:34 AM |
 | Kymera Therapeutics, Inc. (KYMR) realmoney.thestreet.com - February 8 at 12:50 AM |
 | KYMR Crosses Above Average Analyst Target nasdaq.com - February 4 at 8:46 AM |
 | Kymera Therapeutics Strengthens Leadership with Key Appointments and Promotions finance.yahoo.com - February 3 at 9:20 AM |
 | Kymera Therapeutics Is A Protein Degrading Pioneer With A Triple-Figure Share Price In Waiting seekingalpha.com - January 16 at 7:58 AM |
 | Kymera Therapeutics Announces Key 2021 Goals and Milestones to Support its Evolution into a Fully Integrated Degrader Medicines Company finance.yahoo.com - January 12 at 11:24 AM |
 | Kymera Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021 finance.yahoo.com - January 5 at 6:07 PM |
 | Vertex (VRTX) Inks Deal with Skyhawk for Serious Diseases msn.com - December 23 at 12:33 PM |
 | Is KYMR A Good Stock To Buy Now According To Hedge Funds? finance.yahoo.com - December 19 at 8:06 PM |
 | Kymera Therapeutics Announces Key Leadership Appointments finance.yahoo.com - December 16 at 8:43 AM |
 | Kymera Therapeutics Presents Preclinical Data on IRAKIMiD and STAT3 Programs at Virtual 62nd American Society of Hematology (ASH) Annual Meeting finance.yahoo.com - December 7 at 3:59 PM |
 | Analysts Are Betting On Kymera Therapeutics, Inc. (NASDAQ:KYMR) With A Big Upgrade This Week finance.yahoo.com - November 26 at 8:03 AM |
 | Kymera Therapeutics to Present at the Piper Sandler 32nd Annual Healthcare Conference finance.yahoo.com - November 23 at 8:39 AM |
|
 | Kymera Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference finance.yahoo.com - November 11 at 1:03 PM |
 | Kymera Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update finance.yahoo.com - November 5 at 11:08 AM |
 | Kymera's protein degradation programs show encouraging preclinical action in cancer seekingalpha.com - November 4 at 12:41 PM |
 | Kymera Therapeutics to Present Data on Novel IRAKIMiD and STAT3 Protein Degraders at Virtual 62nd American Society of Hematology (ASH) Annual Meeting finance.yahoo.com - November 4 at 12:41 PM |
 | Kymera Reports Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma seekingalpha.com - October 13 at 1:35 PM |
 | Kymera Therapeutics Rings the Opening Bell in Celebration of its IPO nasdaq.com - October 12 at 3:17 PM |
 | Kymera Therapeutics Announces Pricing of Upsized Initial Public Offering finance.yahoo.com - October 1 at 8:31 AM |
 | Kymera Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement finance.yahoo.com - October 1 at 8:31 AM |
 | Kymera Therapeutics Appoints Dr. Richard Chesworth as Chief Scientific Officer finance.yahoo.com - October 1 at 8:31 AM |